Biodesix Inc. - Medical Equipment - Deals and Alliances Profile - GlobalData Financial Mergers and Acquisitions Intelligence

Biodesix Inc. - Medical Equipment - Deals and Alliances Profile

Biodesix Inc. - Medical Equipment - Deals and Alliances Profile - GlobalData Financial Mergers and Acquisitions Intelligence
Biodesix Inc. - Medical Equipment - Deals and Alliances Profile
Published Oct 18, 2016
32 pages — Published Oct 18, 2016
Price US$ 250.00  |  Buy this Report Now

About This Report

  
Abstract:

Summary

Biodesix Inc. (Biodesix) is a biotechnology company that discovers and commercializes blood tests (diagnostics) which help patients and doctors to make more informed decisions about treatment based on a patients unique molecular profile. The tests are used for early detection of diseases, diagnosis accuracy, disease monitoring and to provide improved therapeutic guidance for cancer patients. Biodesixs product portfolio includes GeneStrat, a gene panel of clinically actionable mutations for tumor profiling for patients with advanced lung cancer; and VeriStrat, a serum proteomic test for patients with non-small cell lung cancer.

Biodesix Inc. - Medical Equipment - Deals and Alliances Profile provides you comprehensive data and trend analysis of the company's Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Medical Equipment eTrack deals database, and primary and secondary research.


Scope

- Financial Deals - Analysis of the company's financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year - Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type - Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region - Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector - Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals - Information on the company's major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company's (major public companies) key financial metrics and ratios.
- Business Description - A brief description of the company's operations.
- Key Employees - A list of the key executives of the company.
- Important Locations and Subsidiaries - A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors - A list of the key competitors of the company.
- Key Recent Developments - A brief on recent news about the company.


Reasons to Buy

Get detailed information on the company's financial deals that enable you to understand the company's expansion/divestiture and fund requirements
- The profile enables you to analyze the company's financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company's business segments' expansion / divestiture strategy
- The profile presents deals from the company's core business segments' perspective to help you understand its corporate strategy.

Access elaborate information on the company's recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each

  
Source:
Document ID
GDME86050D
Country
Industry
Format:
PDF Adobe Acrobat
Buy Now

Sections

TitleStarting PageNumber of Pages
Table of Contents23
  List of Tables31
  List of Figures41
Biodesix Inc., Medical Equipment, Deals By Year, 2010 to YTD 201642
Biodesix Inc., Medical Equipment Deals By Type, 2010 to YTD 201661
Biodesix Inc., Medical Equipment, Deals By Region, 2010 to YTD 201671
Biodesix Inc., Medical Equipment, Deals By Market, 2010 to YTD 201681
Biodesix Inc., Medical Equipment, Deals Summary, 2010 to YTD 201691
Biodesix Inc., Medical Equipment, Deal Details1012
  Venture Financing101
    Biodesix Raises USD6 Million in Venture Financing101
    Biodesix Raises USD22 Million in Series F Financing Round111
    Biodesix Raises USD11 Million in Extended Series E Financing121
    Biodesix Raises Additional USD15 Million In Series E Financing Round131
    Biodesix Raises US$10.4 Million In Series E Financing Round141
    Biodesix Raises Up To US$20 Million In Venture Financing151
    Biodesix Raises US$20.8 Million In Extended Series D Financing161
    Biodesix Secures US$20 Million In Series D Financing171
    Biodesix Secures US$7.1 Million In Series C Venture Financing181
  Partnerships191
    Biodesix Forms Partnership with Biognosys191
    Biodesix Enters into Co-Development Agreement with Inivata201
    Biodesix Enters Into Agreement With Bruker Daltonics For VeriStrat211
Biodesix Inc. - Key Competitors221
Key Employees231
Locations And Subsidiaries241
  Head Office241
Recent Developments251
Product News251
Jan 07, 2016: Biodesix GeneStrat Blood-Based Mutation Test Now Includes EML4-ALK Fusions251
Sep 06, 2015: VeriStrat and Epidermal Growth Factor Receptor Mutation Status Study Results Presented at 16th World Conference on Lung Cancer261
May 12, 2015: United Healthcare Approves Coverage for Biodesix VeriStrat Test271
Mar 24, 2015: Lung Cancer Journal: VeriStrat Proteomic Test Improves Overall Survival and Decreases Medical Costs for Patients with Advanced NSCLC281
Other Significant Developments291
Jul 14, 2016: Streck and Biodesix sign exclusive supply agreement for DNA and RNA tubes291
Jul 29, 2015: Biodesix Adds Biognosys Proteomics Technology To Its Diagnostic Development Capabilities; Collaboration Enables Protein Identification Within Proteomic Signatures301
Feb 18, 2015: Biodesix Builds on Investments in Sales, Reimbursement and Government Affairs Growth Strategy311
Appendix321
  Methodology321
  About GlobalData321
  Contact Us321
  Disclaimer321

Table Of Contents

About the Author


Cite this Report

  
MLA:
GlobalData Financial Mergers and Acquisitions Intelligence. "Biodesix Inc. - Medical Equipment - Deals and Alliances Profile" Oct 18, 2016. Alacra Store. Nov 15, 2026. <http://www.alacrastore.com/storecontent/GlobalData-Financial-Mergers-and-Acquisitions-Intelligence/Biodesix-Inc-Medical-Equipment-Deals-and-Alliances-Profile-2148-3632>
  
APA:
GlobalData Financial Mergers and Acquisitions Intelligence. (2016). Biodesix Inc. - Medical Equipment - Deals and Alliances Profile Oct 18, 2016. New York, NY: Alacra Store. Retrieved Nov 15, 2026 from <http://www.alacrastore.com/storecontent/GlobalData-Financial-Mergers-and-Acquisitions-Intelligence/Biodesix-Inc-Medical-Equipment-Deals-and-Alliances-Profile-2148-3632>
  
US$ 250.00
$  £  €
Have a Question?

Any questions about the report you're considering? Our Customer Service Team can help! Or visit our FAQs.

More Research